全文获取类型
收费全文 | 36974篇 |
免费 | 2059篇 |
国内免费 | 154篇 |
专业分类
耳鼻咽喉 | 372篇 |
儿科学 | 817篇 |
妇产科学 | 628篇 |
基础医学 | 6859篇 |
口腔科学 | 866篇 |
临床医学 | 2990篇 |
内科学 | 7204篇 |
皮肤病学 | 890篇 |
神经病学 | 4005篇 |
特种医学 | 1555篇 |
外科学 | 5100篇 |
综合类 | 172篇 |
一般理论 | 15篇 |
预防医学 | 1841篇 |
眼科学 | 739篇 |
药学 | 2537篇 |
中国医学 | 21篇 |
肿瘤学 | 2576篇 |
出版年
2021年 | 371篇 |
2020年 | 325篇 |
2019年 | 525篇 |
2018年 | 611篇 |
2017年 | 470篇 |
2016年 | 616篇 |
2015年 | 713篇 |
2014年 | 838篇 |
2013年 | 1282篇 |
2012年 | 1748篇 |
2011年 | 1903篇 |
2010年 | 1262篇 |
2009年 | 1217篇 |
2008年 | 2023篇 |
2007年 | 2078篇 |
2006年 | 1925篇 |
2005年 | 2081篇 |
2004年 | 1957篇 |
2003年 | 1908篇 |
2002年 | 1971篇 |
2001年 | 486篇 |
2000年 | 402篇 |
1999年 | 527篇 |
1998年 | 566篇 |
1997年 | 463篇 |
1996年 | 440篇 |
1995年 | 379篇 |
1994年 | 320篇 |
1993年 | 300篇 |
1992年 | 299篇 |
1991年 | 311篇 |
1990年 | 278篇 |
1989年 | 251篇 |
1988年 | 264篇 |
1987年 | 239篇 |
1986年 | 215篇 |
1985年 | 241篇 |
1984年 | 254篇 |
1983年 | 224篇 |
1982年 | 248篇 |
1981年 | 203篇 |
1980年 | 163篇 |
1978年 | 190篇 |
1977年 | 167篇 |
1976年 | 165篇 |
1933年 | 170篇 |
1932年 | 180篇 |
1931年 | 167篇 |
1930年 | 169篇 |
1928年 | 163篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Although platelets are the smallest cells in the blood, they are implied in various processes ranging from immunology and oncology to thrombosis and hemostasis. Many large-scale screening programs, genome-wide association, and "omics" studies have generated lists of genes and loci that are probably involved in the formation or physiology of platelets under normal and pathologic conditions. This creates an increasing demand for new and improved model systems that allow functional assessment of the corresponding gene products in vivo. Such animal models not only render invaluable insight in the platelet biology, but in addition, provide improved test systems for the validation of newly developed anti-thrombotics. This review summarizes the most important models to generate transgenic platelets and to study their influence on platelet physiology in vivo. Here we focus on the zebrafish morpholino oligonucleotide technology, the (platelet-specific) knockout mouse, and the transplantation of genetically modified human or murine platelet progenitor cells in myelo-conditioned mice. The various strengths and pitfalls of these animal models are illustrated by recent examples from the platelet field. Finally, we highlight the latest developments in genetic engineering techniques and their possible application in platelet research. 相似文献
992.
993.
Diamond-Blackfan anemia (DBA) is a congenital erythroid hypoplasia caused by a functional haploinsufficiency of genes encoding for ribosomal proteins. Recently, a case study reported a patient who became transfusion-independent in response to treatment with the amino acid L-leucine. Therefore, we have validated the therapeutic effect of L-leucine using our recently generated mouse model for RPS19-deficient DBA. Administration of L-leucine significantly improved the anemia in Rps19-deficient mice (19% improvement in hemoglobin concentration; 18% increase in the number of erythrocytes), increased the bone marrow cellularity, and alleviated stress hematopoiesis. Furthermore, the therapeutic response to L-leucine appeared specific for Rps19-deficient hematopoiesis and was associated with down-regulation of p53 activity. Our study supports the rationale for clinical trials of L-leucine as a therapeutic agent for DBA. 相似文献
994.
For decades, hematopoietic stem cells (HSCs) were thought to be a homogeneous population of cells with flexible behavior. Now a new picture has emerged: The HSC compartment consists of several subpopulations of HSCs each with distinct, preprogrammed differentiation and proliferation behaviors. These programs are epigenetically fixed and are stably bequeathed to all daughter HSCs on self-renewal. HSCs within each subset are remarkably similar in their self- renewal and differentiation behaviors, to the point where their life span can be predicted with mathematical certainty. Three subsets can be distinguished when HSCs are classified by their differentiation capacity: myeloid-biased, balanced, and lymphoid-biased HSCs. The relative number of the HSC subsets is developmentally regulated. Lymphoid-biased HSCs are found predominantly early in the life of an organism, whereas myeloid-biased HSCs accumulate in aged mice and humans. Thus, the discovery of distinct subpopulations of HSCs has led to a new understanding of HCS aging. This finding has implications for other aspects of HSC biology and applications in re-generative medicine. The possibility that other adult tissue stem cells show similar heterogeneity and mechanisms of aging is discussed. 相似文献
995.
Abdollahpour H Appaswamy G Kotlarz D Diestelhorst J Beier R Schäffer AA Gertz EM Schambach A Kreipe HH Pfeifer D Engelhardt KR Rezaei N Grimbacher B Lohrmann S Sherkat R Klein C 《Blood》2012,119(15):3450-3457
We describe a novel clinical phenotype associating T- and B-cell lymphopenia, intermittent neutropenia, and atrial septal defects in 3 members of a consanguineous kindred. Their clinical histories included recurrent bacterial infections, viral infections, mucocutaneous candidiasis, cutaneous warts, and skin abscesses. Homozygosity mapping and candidate gene sequencing revealed a homozygous premature termination mutation in the gene STK4 (serine threonine kinase 4, formerly having the symbol MST1). STK4 is the human ortholog of Drosophila Hippo, the central constituent of a highly conserved pathway controlling cell growth and apoptosis. STK4-deficient lymphocytes and neutrophils exhibit enhanced loss of mitochondrial membrane potential and increased susceptibility to apoptosis. STK4 deficiency is a novel human primary immunodeficiency syndrome. 相似文献
996.
997.
998.
Stocks T Van Hemelrijck M Manjer J Bjørge T Ulmer H Hallmans G Lindkvist B Selmer R Nagel G Tretli S Concin H Engeland A Jonsson H Stattin P 《Hypertension》2012,59(4):802-810
Observational studies have shown inconsistent results for the association between blood pressure and cancer risk. We investigated the association in 7 cohorts from Norway, Austria, and Sweden. In total, 577799 adults with a mean age of 44 years were followed for, on average, 12 years. Incident cancers were 22184 in men and 14744 in women, and cancer deaths were 8724 and 4525, respectively. Cox regression was used to calculate hazard ratios of cancer per 10-mmHg increments of midblood pressure, which corresponded with 0.7 SDs and, for example, an increment of systolic/diastolic blood pressure of 130/80 to 142/88 mmHg. All of the models used age as the time scale and were adjusted for possible confounders, including body mass index and smoking status. In men, midblood pressure was positively related to total incident cancer (hazard ratio per 10 mmHg increment: 1.07 [95% CI: 1.04-1.09]) and to cancer of the oropharynx, colon, rectum, lung, bladder, kidney, malignant melanoma, and nonmelanoma skin cancer. In women, midblood pressure was not related to total incident cancer but was positively related to cancer of the liver, pancreas, cervix, uterine corpus, and malignant melanoma. A positive association was also found for cancer mortality, with HRs per 10-mmHg increment of 1.12 (95% CI: 1.08-1.15) for men and 1.06 (95% CI: 1.02-1.11) for women. These results suggest a small increased cancer risk overall in men with elevated blood pressure level and a higher risk for cancer death in men and women. 相似文献
999.
1000.
Steinmann D Maertens B Janssen S Werner M Frühauf J Nakamura M Christiansen H Bremer M 《Journal of cancer research and clinical oncology》2012,138(9):1523-1529